Drug
nilotinib
Marketed as DANZITEN.
Generic name
nilotinib
Brand names
DANZITEN
First FDA approval
2024-11-07
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA219293 | DANZITEN | 2024-11-07 | AZURITY |
Manufacturers
AZURITY
Frequently asked questions
When was nilotinib FDA approved?
Earliest FDA approval on record: 2024-11-07.
What brand names are sold as nilotinib?
DANZITEN.
Sources
Appeal a nilotinib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com